![Verteporfin-mediated on/off photoswitching functions synergistically to treat choroidal vascular diseases - ScienceDirect Verteporfin-mediated on/off photoswitching functions synergistically to treat choroidal vascular diseases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2452199X22000391-ga1.jpg)
Verteporfin-mediated on/off photoswitching functions synergistically to treat choroidal vascular diseases - ScienceDirect
![Verteporfin | YAP inhibitor | Visudyne | CAS [129497-78-5] | Axon 3354 | Axon Ligand™ with >99% purity available from stock from supplier Axon Medchem Verteporfin | YAP inhibitor | Visudyne | CAS [129497-78-5] | Axon 3354 | Axon Ligand™ with >99% purity available from stock from supplier Axon Medchem](https://www.axonmedchem.com/media/catalog/product/cache/1/image/9df78eab33525d08d6e5fb8d27136e95/3/3/3354.gif)
Verteporfin | YAP inhibitor | Visudyne | CAS [129497-78-5] | Axon 3354 | Axon Ligand™ with >99% purity available from stock from supplier Axon Medchem
![These highlights do not include all the information needed to use VISUDYNE safely and effectively. See full prescribing information for VISUDYNE. VISUDYNE® (verteporfin for injection), for intravenous useInitial U.S. Approval: 2000 These highlights do not include all the information needed to use VISUDYNE safely and effectively. See full prescribing information for VISUDYNE. VISUDYNE® (verteporfin for injection), for intravenous useInitial U.S. Approval: 2000](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-02.jpg&id=637077)